VanEck Biotech ETF (BBH)

Profile

https://www.vaneck.com/us/en/investments/biotech-etf-bbh/

VanEck Biotech ETF is an exchange-traded fund focused on the biotechnology industry. It seeks to track the MVIS US Listed Biotech 25 Index, giving investors exposure to a concentrated group of U.S.-listed biotech companies involved in drug development, genetic analysis, diagnostics, and related life sciences activities. The fund is designed to follow a rules-based, passively managed approach and typically emphasizes established companies that generate most of their business from biotechnology research, production, marketing, or sales. VanEck Biotech ETF plays a specialized role in the market by providing targeted access to a sector that is central to healthcare innovation, therapeutic development, and scientific commercialization. Its portfolio structure makes it a focused vehicle for participation in the biotech segment rather than the broader healthcare market.